Thyrocare Technologies Q3 Results | EBITDA surged 32.4%, while the EBITDA margin stood at 25.1% versus 23.4% in the year-ago quarter. Shares of Thyrocare Technologies Ltd ended at ₹787.80, down by ₹10.25, or 1.28%, on the BSE.
Your email address will not be published. Required fields are marked *
Name*
Email*
Website
Save my name, email, and website in this browser for the next time I comment.